Venetoclax and Sequential Busulfan, Cladribine, and Fludarabine Phosphate Before Donor Stem Cell Transplant in Treating Patients With Acute Myelogenous Leukemia or Myelodysplastic Syndrome
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Roswell Park Cancer Institute
Fred Hutchinson Cancer Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Novartis
St. Jude Children's Research Hospital
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Massachusetts General Hospital
M.D. Anderson Cancer Center
Incyte Corporation
National Cancer Institute (NCI)
Massachusetts General Hospital
Novartis
Dana-Farber Cancer Institute
Massachusetts General Hospital
CareDx
Center for International Blood and Marrow Transplant Research
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Orca Biosystems, Inc.
Auron Therapeutics, Inc.
Washington University School of Medicine
M.D. Anderson Cancer Center
Faron Pharmaceuticals Ltd
City of Hope Medical Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Memorial Sloan Kettering Cancer Center
University of Miami
Center for International Blood and Marrow Transplant Research
St. Jude Children's Research Hospital
University of Southern California
St. Jude Children's Research Hospital
City of Hope Medical Center
Dana-Farber Cancer Institute
University of Michigan Rogel Cancer Center
Fred Hutchinson Cancer Center
University of Illinois at Chicago
M.D. Anderson Cancer Center
Memorial Sloan Kettering Cancer Center
Novartis
Geron Corporation
Dana-Farber Cancer Institute
Dana-Farber Cancer Institute
Children's Oncology Group
National Cancer Institute (NCI)
M.D. Anderson Cancer Center
City of Hope Medical Center